In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease.
This report contains market size and forecasts of IVD Infectious Diseases in Global, including the following market information:
Global IVD Infectious Diseases Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global IVD Infectious Diseases market was valued at 17100 million in 2021 and is projected to reach US$ 21950 million by 2028, at a CAGR of 3.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immunochemistry Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of IVD Infectious Diseases include BD, BioMerieux, Abbott, Quidel, Gen-Probe, Abbott, Danaher, Sysmex and Orasure, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IVD Infectious Diseases companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global IVD Infectious Diseases Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global IVD Infectious Diseases Market Segment Percentages, by Type, 2021 (%)
Immunochemistry
Molecular Diagnostics
Global IVD Infectious Diseases Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global IVD Infectious Diseases Market Segment Percentages, by Application, 2021 (%)
Clinical Laboratories
Diagnostic Centers
Global IVD Infectious Diseases Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global IVD Infectious Diseases Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies IVD Infectious Diseases revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies IVD Infectious Diseases revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD
BioMerieux
Abbott
Quidel
Gen-Probe
Abbott
Danaher
Sysmex
Orasure
Hologic
Cepheid
Qiagen
Roche Diagnostics
Siemens Healthcare
Bio-Rad Laboratories